Sickle Cell Disease Partnership
Alliance of patient advocates, plans, providers & manufacturers focused on federal policy.
Based in DC
🤖
AI Overview
With $500K in lobbying spend across 16 quarterly filings, Sickle Cell Disease Partnership is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
$500K
Total Spend
4
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $80K |
| 2023 | $130K |
| 2024 | $180K |
| 2025 | $110K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Advocating for federal health care policies based on the National Academies 2020 report that will improve the lives of patients living with Sickle Cell Disease.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.